On August 31, 2023, DEA published a final rule (“Final Rule”) regarding its management of controlled substance and List 1 Chemical (“L1 Chemical”) quotas for DEA-registered manufacturers. The Final Rule largely tracks DEA’s...more
9/6/2023
/ Controlled Substances ,
DEA ,
Final Rules ,
Food and Drug Administration (FDA) ,
Inventory ,
Life Sciences ,
Manufacturers ,
Notice of Proposed Rulemaking (NOPR) ,
Pharmaceutical Industry ,
Procurement Guidelines ,
Product Development Protocols ,
Product Labels ,
Quotas ,
Schedule I Drugs ,
Supply Chain
On March 16, 2023, the Food and Drug Administration (FDA) released final guidance regarding definitions of "suspect product" and "illegitimate product" as part of a continued effort to prepare trading partners for the...more
3/22/2023
/ Counterfeit Drugs ,
Drug Distribution ,
DSCSA ,
Federal Food Drug and Cosmetic Act (FFDCA) ,
Final Guidance ,
Food & Drug Regulations ,
Food and Drug Administration (FDA) ,
Healthcare ,
Life Sciences ,
Pharmaceutical Industry ,
Prescription Drugs ,
Stolen Goods